Arthur Taveras, Chief Scientific Officer: X4 Pharmaceuticals XFOR Sell · Filed 23/02/15

Trade details

Type: Insider sale
Amount: $863.04
Shares · price: 928 sh · $0.93 a share
Held after: 103,179 sh
Stock: X4 Pharmaceuticals XFOR
Person: Arthur TaverasChief Scientific Officer
Trade date: 23/02/13
Filed: 23/02/15
Days to filing: 2 days

Sold 0.9% of holdings

Share of holding sold: 0.9%

X4 Pharmaceuticals trades, last 26 weeks

What else happened in X4 Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/01/14~23/03/15

Arthur Taveras's recent trades

Arthur TaverasOfficer
Planned sale10b5-1 planX4 Pharmaceuticals
Planned sale10b5-1 plan
X4 Pharmaceuticals
XFOR
$12.9K
24,828 sh
$12.9K
Filed 25/01/24
Traded 25/01/24
Arthur TaverasChief Scientific Officer
SellX4 Pharmaceuticals
Sell
X4 Pharmaceuticals
XFOR
$43.1K
76,920 sh
$43.1K
Filed 24/10/08
Traded 24/10/07
Arthur TaverasChief Scientific Officer
SellX4 Pharmaceuticals
Sell
X4 Pharmaceuticals
XFOR
$12.5K
14,235 sh
$12.5K
Filed 24/03/11
Traded 24/03/11
Arthur TaverasChief Scientific Officer
SellX4 Pharmaceuticals
Sell
X4 Pharmaceuticals
XFOR
$795
787 sh
$795
Filed 24/02/12
Traded 24/02/12
Arthur TaverasChief Scientific Officer
Sell10b5-1 planX4 Pharmaceuticals
Sell10b5-1 plan
X4 Pharmaceuticals
XFOR
$49.4K
67,695 sh
$49.4K
Filed 23/11/03
Traded 23/11/01